Physical activity and the incidence of multiple sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 11, 2016
- Accepted in final form July 6, 2016
- First Published September 28, 2016.
Article Versions
- Previous version (September 28, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Kirsten S. Dorans, ScD,
- Jennifer Massa, ScD,
- Tanuja Chitnis, MD,
- Alberto Ascherio, MD, DrPH and
- Kassandra L. Munger, ScD
- Kirsten S. Dorans, ScD,
NONE
NONE
(1) Non-profit: American Heart Association, Epidemiology and Prevention Early Career Travel Grant
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) National Institutes of Health, T32 HL007575, Trainee, 2011-2016 (2) National Institutes of Health, R01NS046635, Received support from grant, 2012-2013
NONE
(1) Antarctic Science Ltd. (Spouse received funding in 2015. It is
NONE
NONE
NONE
NONE
NONE
NONE
- Jennifer Massa, ScD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tanuja Chitnis, MD,
Dr. Chitnis has served on clinical trial advisory boards for Novartis Pharmaceuticals, and Genzyme-Sanofi.
NONE
NONE
NONE
NONE
NONE
NONE
Dr. Chitnis has served as a one-time consultant for Biogen-Idec, Novartis, Genzyme-Sanofi and Genentech-Roche.
NONE
NONE
NONE
Dr. Chitnis receives research support from (1) EMD-Serono, (2) Novartis, (3) Biogen (4) Verily, in the form of Independent Investigator Awards.
NONE
NONE
Dr. Chitnis receives research support from the National Multiple Sclerosis Society, the Peabody Foundation, the Consortium for MS Centers and the Guthy-Jackson Charitable Foundation.
NONE
NONE
NONE
NONE
NONE
NONE
- Alberto Ascherio, MD, DrPH and
Michael J Fox Foundation 2005-present Bayer Healthcare 2014
NONE
Roche, speaker honorarium, 2012
1) Annals of Neurology, Associate Editor 2) Multiple Sclerosis and Related Disorders, Associate Editor 3) Journal of Parkinson Disease, Associate Editor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH R01 NS061858; 2009-2014; Role: PI NIH R01 NS071082; 2012-2014; Role: PI NIH R01 NS046635; 2008-2015; Role: PI NIH R01 ES019188; 2010-2015; Role: Co-Investigator NIH R01 NS072494; 2011-2014; Role: Co-Investigator NIH R01 NS073633; 2011-present; Role: PI DoD W81XWH-14-1-0131; 2014-present; Role: PI NIH R01 NS045893; 2013-present; Role: PI NIH 1U01NS-90259; 2015-present; Role: Co-Investigator NIH R01 NS089619-01A1; 2015-present; Role: PI NIH R01 NS097723; 2016-present; Role: Co-Investigator
NONE
ALS Therapy Alliance - No award number; 2012-2014; Role: PI NMSS RG4875A/1; 2013-2015; Role: PI NMSS RG5146-A-1; 2014-present; Role: Co-Investigator NMSS RG1501-03068; 2015-present; Role: Co-Investigator
NONE
NONE
NONE
NONE
NONE
NONE
- Kassandra L. Munger, ScD
NONE
NONE
1) Travel/honorarium. Sponsor: Croatian International Conference on Multiple Sclerosis and Related Autoimmune Disorders. Invited Speaker, Zagreb, Croatia March 5-7, 2015 2) Travel/honorarium. Sponsor: American Society for Experimental NeuroTherapeutics. Invited Speaker, Bethesda MD March 19, 2016
1) Multiple Sclerosis Journal, Editorial Board member, 2013-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH-NINDS, 1 R01 NS046635, Co-investigator, 6/1/08-present
NONE
1) National Multiple Sclerosis Society
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Epidemiology (K.S.D., A.A.) and Nutrition (J.M., A.A., K.L.M.), Harvard T.H. Chan School of Public Health; Cardiovascular Epidemiology Research Unit, Department of Medicine, Beth Israel Deaconess Medical Center (K.S.D.), Channing Division of Network Medicine, Department of Medicine (A.A.), and Partners Multiple Sclerosis Center, Department of Neurology (T.C.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Correspondence to Dr. Munger: kgorham{at}hsph.harvard.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan